Merck & Co.

Merck hands over $20M in IBD target deal with Quotient

After generating interest from Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted another Big Pharma suitor in Merck & Co.

Fraiser Kansteiner Mar 24, 2026 6:00am

weigh scale goliath outweigh balance bigger smaller even

BioNTech’s B7-H3 ADC hits ph. 3 at half the size of Merck’s

Feb 27, 2026 10:31pm

Cardiff Oncology churns C-suite—Chutes & Ladders

Jan 30, 2026 8:30am

Completing steps towards success checkmark on cubes symbolizing progress

Merck, Moderna sustain 49% melanoma risk reduction at 5 years

Jan 20, 2026 8:50am

Guardant Health pens Merck & Co. cancer collab

Jan 19, 2026 8:10am

Fierce Pharma

Exelixis aims to be a top 5 solid tumor drugmaker in the US: CEO

Jan 16, 2026 1:00pm